# Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

> **NCT07135427** · PHASE4 · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 30 (estimated)

## Conditions studied

- Alpha 1-Antitrypsin
- COPD
- Antibody Deficiency

## Interventions

- **BIOLOGICAL:** 20-valent pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT07135427
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135427, "Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07135427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*